Brief: Vallon Pharmaceuticals Announces Topline Results Of Its Pivotal Seal Study For Lead Program, Adair, For The Treatment Of Adhd
NASDAQ RESUMED AT 07:30 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Brief: Vallon Pharmaceuticals Announces Appointment Of Meenu Karson To Board Of Directors
Brief: Vallon Pharmaceuticals Inc Increased Size Of Board From Five Directors To Six Directors
Brief: Vallon Pharma Gets U.S. Patent Covering Adair For Treatment Of Cognitive Impairment Associated With COVID-19
Brief: Vallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results And Provides Business Update
Brief: Vallon Pharmaceuticals Presents New Data From Adult Stimulant Abuse Pattern Survey At Apsard 2022 Annual Conference
Brief: Vallon Pharmaceuticals Announces Achievement Of Last Patient Last Visit In Pivotal Seal Study For Lead Program, Adair
U.S. STOCKS ON THE MOVE-Nordstrom, Gap, HP Inc, Chevron
U.S. STOCKS ON THE MOVE-HP Inc, Gap Inc, Nordstrom, Qualcomm
U.S. STOCKS ON THE MOVE-Zoom, Gap Inc, Chevron
U.S. STOCKS ON THE MOVE-Zoom, Tesla, Chevron
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:40 PM
Brief: Vallon Pharmaceuticals Reports Qtrly Net Loss Of $1.3 Mln
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:18 PM
Brief: Vallon Pharmaceuticals Inc Provides Update On Recent Pipeline And Corporate Advancements
Brief: Vallon Pharmaceuticals Reports Formation Of Scientific Advisory Board
U.S. STOCKS ON THE MOVE-Zoom, Virgin Galactic, Chico's FAS, Chinese tech stocks, U.S. pharmas